MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$2,423K
EPS
-$0.89
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
General and administrative
1,629
1,916
1,212*
1,814
Research and development
876
773
704*
1,275
Total operating expenses
2,505
2,689
1,916
3,089
Loss from operations
-2,505
-2,689
-1,916*
-3,089
Gain on investment
-
-
6*
-
Interest income
42
1
-
5
Interest expense
6
100
-80*
111
Loss on extinguishment of debt - related party
-
-
83*
-
Interest expense - related party
0
24
-
-
Net change in fair value of derivative liability
0
-146
-1,098*
75
Interest expense - related party
-
-
21*
-
Net change in fair value of trading marketable securities
-
-
0*
0
Gain on extinguishment of debt
42
-
-206*
-
Total other income (expense)
78
-269
-1,322*
-31
Provision for income taxes
0
-
0*
0
Net loss
-2,427
-2,958
-3,238*
-3,120
Foreign currency translation adjustments
4
26
-124
18
Total other comprehensive income (loss)
4
26
-124*
18
Total comprehensive loss
-2,423
-2,932
-3,362
-3,102
Diluted EPS
-0.89
-4
-1.948
-3.97
Diluted Average Shares
2,712,000
739,000
1,726,000
787,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Foreign currency
translation adjustments
$4K
(105.88%↑ Y/Y)
Total comprehensive
loss
-$2,423K
(26.33%↑ Y/Y)
Total other
comprehensive income (loss)
$4K
Gain on
extinguishment of debt
$42K
Interest income
$42K
(4100.00%↑ Y/Y)
Net loss
-$2,427K
(24.65%↑ Y/Y)
Total other income
(expense)
$78K
(209.86%↑ Y/Y)
Interest expense
$6K
(-91.67%↓ Y/Y)
Loss from operations
-$2,505K
(20.48%↑ Y/Y)
Total operating
expenses
$2,505K
(-20.48%↓ Y/Y)
General and
administrative
$1,629K
(27.37%↑ Y/Y)
Research and development
$876K
(-53.18%↓ Y/Y)
Buy us a coffee
ARTELO BIOSCIENCES, INC. (ARTL)
ARTELO BIOSCIENCES, INC. (ARTL)